USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
European Respiratory Diseases Market
European Respiratory Diseases Market
RELEASE DATE
10-Aug-2006
10-Aug-2006
REGION
Europe
Europe
Research Code: H043-01-00-00-00
SKU: HC01569-EU-MR_06176
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC01569-EU-MR_06176
Description
The research service covers the respiratory market especially the asthma/COPD market in Europe with emphasis on drivers, restraints, challenges and market revenues.
Table of Contents
Executive Summary Of The European Respiratory Diseases Market
- Market Summary
Research Objectives and Scope
- Research Methodology
Challenges Facing the European Respiratory Diseases Market
- Industry Challenges
Respiratory Diseases
- Disease Description
- Epidemiology
- Current Treatments
Market Engineering Research
- Market Overview
- Market Engineering Measurements
- Trend by Segments
- Market Drivers
- Market Restraints
- Competitive Structure
- Revenue Forecasts
Portfolio Analysis
- GlaxoSmithKline
- Boehringer Ingelheim GmbH
- AstraZeneca
- Merck & Co.Inc.
- ALTANA Pharma AG
- Novartis AG
Market Engineering Recommendations
- Strategic Recommendations
Key Industry Participants
- Major Participants
Decision Support Database
- Asthma Prevalence
- Asthma Prevalence Per Cent
- COPD Prevalence
- Asthma Bronchitis Emphysema Mortality
- Respiratory Mortality
The research service covers the respiratory market especially the asthma/COPD market in Europe with emphasis on drivers, restraints, challenges and market revenues.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | H043-01-00-00-00 |
| Is Prebook | No |